Top

Arch Biopartners Inc.

TSXV Exchange | Apr 2, 2020, 10:10 PM EDT | Real-time price

ARCH $ 0.90 RT
CHANGE
-0.02 (-2.1739%)
VOLUME
18,005
Day Low: 0.89
Day High: 0.92
Detailed Quote
Open: 0.92
High: 0.92
Beta: -0.07782
Shares Out.: 59,882,302
Total Shares (All Classes)2: 59,882,302
Prev. Close: 0.92
Low: 0.89
VWAP: 0.9017
Escrow Shares: 0
Market Cap (All Classes)2*: 53,894,072
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Listed Shares Out.1: 59,882,302
EPS: -0.04
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: -15.00
Market Cap1: 53,894,072
Exchange: TSXV

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. Its under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm... More

News Headlines for Arch Biopartners Inc.
Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links
News Headlines for Arch Biopartners Inc.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.